Fertility startup Gameto has received permission from the FDA to see if its ovary-in-a-dish technology can make in vitro ...
VC, a venture capital firm that has spread its bets across multiple industries, including biotech and digital health, is ...
Zentalis Pharmaceuticals is axing about 40% of its staff and doubling down on advancing its only pipeline candidate as part ...
Teva CEO Richard Francis expects continued growth for Austedo despite future Medicare price negotiations, maintaining $2.5B ...
A Delaware judge issued a split ruling in a bizarre legal squabble over the IPO plans of Aurion Biotech, which should allow ...
The Trump administration said on Wednesday it will consider “opportunities to bring greater transparency” to the ...
Eli Lilly is discontinuing a Phase 2 relaxin treatment candidate for heart failure and chronic kidney disease, a spokesperson ...
Curie.Bio reveals $340M seed fund, Cullinan's zipalertinib succeeds in lung cancer trial, Benchling cuts 10% staff, I-Mab reduces workforce, Regulus shares Phase 1b data, Imvax raises $29M ...
Lonza said Wednesday morning it is on the hunt for deals to increase its capacity and technology offerings, which comes after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback